Pharmaceutical Sector: Sequentially Flattish Quarter Expected
4QFY22 is expected to be a flattish quarter for most Pharma companies in our coverage universe. We expect a few companies to benefit from the US...
325 Views
Continuously outpacing domestic growth
JB Chemicals & Pharmaceuticals’ (JBCPL) Q3FY22 performance was better than our estimates on operational fronts. Excluding revenue deferred to...
195 Views
Industry beating growth in India drives Q2
JB Chemicals & Pharmaceuticals’ (JBCPL) Q2FY22 performance was better than estimates driven by strong growth in India business. EBITDA margin was...
152 Views
Last Week In Event SPACE: FamilyMart, Sina, Line Corp, Metlifecare, Accordia Golf, Jingjeng, O-Net
Last Week in Event SPACE ... Interestingly, the impact of FamilyMart Co Ltd (8028 JP)'s shareholder dynamic on price may not be what "smart"...
444 Views
J.B.Chemicals (JBCP IN): Partial Tender Offer by KKR
The Promoters of J.B. Chemicals & Pharma (JBCP IN)announced on 3rd July they had signed an SPA with KKR & Co Inc (KKR US) to sell up to 54%...
381 Views